These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 20307216

  • 21. Bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension.
    Curran MP.
    Drugs Aging; 2009; 26(12):1049-71. PubMed ID: 19929032
    [Abstract] [Full Text] [Related]

  • 22. Travoprost 0.004%/timolol 0.5% fixed combination in patients transitioning from fixed or unfixed bimatoprost 0.03%/timolol 0.5%.
    Scherzer ML, Liehneova I, Negrete FJ, Schnober D.
    Adv Ther; 2011 Aug; 28(8):661-70. PubMed ID: 21773673
    [Abstract] [Full Text] [Related]

  • 23. Intraocular Pressure-Lowering Activity of NCX 470, a Novel Nitric Oxide-Donating Bimatoprost in Preclinical Models.
    Impagnatiello F, Toris CB, Batugo M, Prasanna G, Borghi V, Bastia E, Ongini E, Krauss AH.
    Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6558-64. PubMed ID: 26457541
    [Abstract] [Full Text] [Related]

  • 24. Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells.
    Sharif NA, Kelly CR, Crider JY, Williams GW, Xu SX.
    J Ocul Pharmacol Ther; 2003 Dec; 19(6):501-15. PubMed ID: 14733708
    [Abstract] [Full Text] [Related]

  • 25. The effects of prostaglandin analogues on the blood aqueous barrier and corneal thickness of phakic patients with primary open-angle glaucoma and ocular hypertension.
    Arcieri ES, Pierre Filho PT, Wakamatsu TH, Costa VP.
    Eye (Lond); 2008 Feb; 22(2):179-83. PubMed ID: 16936646
    [Abstract] [Full Text] [Related]

  • 26. Bimatoprost 0.03% preservative-free ophthalmic solution versus bimatoprost 0.03% ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week, randomised, double-masked trial.
    Day DG, Walters TR, Schwartz GF, Mundorf TK, Liu C, Schiffman RM, Bejanian M.
    Br J Ophthalmol; 2013 Aug; 97(8):989-93. PubMed ID: 23743437
    [Abstract] [Full Text] [Related]

  • 27. Mechanism of action of bimatoprost, latanoprost, and travoprost in healthy subjects. A crossover study.
    Lim KS, Nau CB, O'Byrne MM, Hodge DO, Toris CB, McLaren JW, Johnson DH.
    Ophthalmology; 2008 May; 115(5):790-795.e4. PubMed ID: 18452763
    [Abstract] [Full Text] [Related]

  • 28. Inter-visit intraocular pressure range: an alternative parameter for assessing intraocular pressure control in clinical trials.
    Varma R, Hwang LJ, Grunden JW, Bean GW.
    Am J Ophthalmol; 2008 Feb; 145(2):336-42. PubMed ID: 18222194
    [Abstract] [Full Text] [Related]

  • 29. Comparison of the efficacy and safety of bimatoprost (0.03 %) and travoprost (0.004 %) in patients with primary open angle glaucoma.
    Chander A, Kapoor H, Thomas S.
    Nepal J Ophthalmol; 2013 Feb; 5(1):75-80. PubMed ID: 23584651
    [Abstract] [Full Text] [Related]

  • 30. [Cystoid macular edema in a pseudophakic patient after several glaucoma procedures. Is local therapy with bimatoprost the reason?].
    Kruse P, Rieck P, Sherif Z, Liekfeld A.
    Klin Monbl Augenheilkd; 2006 Jun; 223(6):534-7. PubMed ID: 16804825
    [Abstract] [Full Text] [Related]

  • 31. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
    Stewart WC, Konstas AG, Nelson LA, Kruft B.
    Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886
    [Abstract] [Full Text] [Related]

  • 32. Pharmacokinetics and intraocular pressure-lowering activity of TAK-639, a novel C-type natriuretic peptide analog, in rabbit, dog, and monkey.
    Savinainen A, Prusakiewicz JJ, Oswald J, Spencer E, Lou Z, Cohen ML, Rashidzadeh H, Josiah S.
    Exp Eye Res; 2019 Dec; 189():107836. PubMed ID: 31626797
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. A meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapy.
    Denis P, Lafuma A, Khoshnood B, Mimaud V, Berdeaux G.
    Curr Med Res Opin; 2007 Mar; 23(3):601-8. PubMed ID: 17355741
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Effect of bimatoprost on intraocular pressure after cataract surgery.
    Unal M, Yücel I.
    Can J Ophthalmol; 2008 Dec; 43(6):712-6. PubMed ID: 19020639
    [Abstract] [Full Text] [Related]

  • 39. Agonist activity of bimatoprost, travoprost, latanoprost, unoprostone isopropyl ester and other prostaglandin analogs at the cloned human ciliary body FP prostaglandin receptor.
    Sharif NA, Kelly CR, Crider JY.
    J Ocul Pharmacol Ther; 2002 Aug; 18(4):313-24. PubMed ID: 12222762
    [Abstract] [Full Text] [Related]

  • 40. Mechanism of action of bimatoprost (Lumigan).
    Brubaker RF.
    Surv Ophthalmol; 2001 May; 45 Suppl 4():S347-51. PubMed ID: 11434937
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.